CERS Cerus Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: CERS

Price (delayed)

$1.7

Market cap

$308.18M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.21

Enterprise value

$390.82M

Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies ...

Highlights
The quick ratio rose by 30% year-on-year and by 17% since the previous quarter
The company's net income rose by 25% QoQ and by 12% YoY
CERS's equity is down by 22% year-on-year but it is up by 9% since the previous quarter
Cerus's debt has increased by 10% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.cerus.com
Peers: HAE BSX MLSS BIOL

Key stats

What are the main financial stats of CERS
Market
Shares outstanding
181.28M
Market cap
$308.18M
Enterprise value
$390.82M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.85
Price to sales (P/S)
1.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.09
Earnings
Revenue
$186.8M
EBIT
-$28.78M
EBITDA
-$23.87M
Free cash flow
-$47.77M
Per share
EPS
-$0.21
Free cash flow per share
-$0.26
Book value per share
$0.29
Revenue per share
$1.04
TBVPS
$1.09
Balance sheet
Total assets
$197.75M
Total liabilities
$144.3M
Debt
$96M
Equity
$52.65M
Working capital
$76.92M
Liquidity
Debt to equity
1.82
Current ratio
2.14
Quick ratio
1.53
Net debt/EBITDA
-3.46
Margins
EBITDA margin
-12.8%
Gross margin
62.5%
Net margin
-20.1%
Operating margin
-16.1%
Efficiency
Return on assets
-18.5%
Return on equity
-71.3%
Return on invested capital
-14.6%
Return on capital employed
-22.1%
Return on sales
-15.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CERS stock price

How has the Cerus stock price performed over time
Intraday
2.41%
1 week
3.66%
1 month
-2.86%
1 year
-30.04%
YTD
-21.3%
QTD
-10.05%

Financial performance

How have Cerus's revenue and profit performed over time
Revenue
$186.8M
Gross profit
$116.83M
Operating income
-$30.05M
Net income
-$37.49M
Gross margin
62.5%
Net margin
-20.1%
CERS's operating income is up by 27% since the previous quarter and by 12% year-on-year
Cerus's operating margin has increased by 27% QoQ and by 11% YoY
Cerus's net margin has increased by 25% QoQ and by 11% YoY
The company's net income rose by 25% QoQ and by 12% YoY

Growth

What is Cerus's growth rate over time

Valuation

What is Cerus stock price valuation
P/E
N/A
P/B
5.85
P/S
1.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.09
CERS's EPS is up by 22% since the previous quarter and by 13% year-on-year
CERS's price to book (P/B) is 43% lower than its 5-year quarterly average of 10.3 and 25% lower than its last 4 quarters average of 7.8
CERS's equity is down by 22% year-on-year but it is up by 9% since the previous quarter
The stock's price to sales (P/S) is 74% less than its 5-year quarterly average of 6.3 and 25% less than its last 4 quarters average of 2.2

Efficiency

How efficient is Cerus business performance
The ROIC has grown by 36% from the previous quarter and by 28% YoY
CERS's return on sales is up by 31% since the previous quarter and by 21% year-on-year
Cerus's return on assets has increased by 23% QoQ and by 6% YoY
CERS's return on equity is down by 23% year-on-year but it is up by 19% since the previous quarter

Dividends

What is CERS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CERS.

Financial health

How did Cerus financials performed over time
CERS's total assets is 37% greater than its total liabilities
Cerus's current ratio has increased by 48% YoY and by 14% QoQ
The quick ratio rose by 30% year-on-year and by 17% since the previous quarter
Cerus's debt is 82% higher than its equity
Cerus's debt to equity has increased by 41% YoY but it has decreased by 8% QoQ
CERS's equity is down by 22% year-on-year but it is up by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.